Skip to content

Nuvectis Pharma, Inc. NVCT Book value per share

Book value per share at other companies

Pfizer logo
PfizerPFE
$15.72-0.6%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$1.52+372%
Relmada Therapeutics, Inc. logo
Relmada Therapeutics, Inc.RLMD
$2.53+242%
Nuvation Bio logo
Nuvation BioNUVB
$0.85-31.7%
Immunome logo
ImmunomeIMNM
$5.20+34.5%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$4.18-22.6%

Other financials

Income statement

See full
Operating income-$6.3M-12.4%
Net income-$6.1M-13.5%
EPS (diluted)-$0.26+3.7%

Balance sheet

See full
Cash & equivalents$25.1M-15.9%
Total equity$14.2M-32.1%
Total assets$25.4M-15.8%

Cash flow

See full
Operating cash flow-$6.5M-56.0%

Valuation

See full
Market cap$739.27M+335%

Returns & leverage

See full
Return on equity-154.4%+79.4pp
Current ratio2.3×-1.0×

Where this comes from

Calculated from Nuvectis Pharma, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Nuvectis Pharma, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvectis Pharma, Inc.'s book value per share.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvectis Pharma, Inc.'s book value per share?
Nuvectis Pharma, Inc. (NVCT) reported book value per share of $0.61 in Q1 2026.
How has Nuvectis Pharma, Inc.'s book value per share changed year-over-year?
Nuvectis Pharma, Inc.'s book value per share decreased by 42.2% year-over-year, from $1.05 to $0.61.
What is the long-term trend for Nuvectis Pharma, Inc.'s book value per share?
Over 4 years (2021 to 2025), Nuvectis Pharma, Inc.'s book value per share has grown at a -24.4% compound annual growth rate (CAGR), from -$2.58 to $0.84.
What does book value per share mean?
Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.